Nicolab Investment Opportunity
Wholesale Only*
Nicolab is a medtech company which uses artificial intelligence (AI) to accelerate the diagnosis of stroke emergencies, offering the potential to boost patients’ life quality after an incident and save the health system billions of dollars.
AI-driven medtech scaling up in partnership with industry giant
When having a stroke, getting treated by a specialist is highly time-critical. However, 60% of stroke patients arrive at emergency departments out of hours when no specialist is present leading to delays in 40% of all stroke emergency triages.
Nicolab’s easy-to-implement software solution enables a fast AI-assisted diagnosis with its picture sharing and communication platform allowing specialists to make their assessment remotely and therefore much faster.
With commercial contracts signed in the US, Europe and APAC for their FDA-cleared solution as well as a partnership with $28bn medtech giant Philips, Nicolab is now accelerating their commercial scale up across the globe.
The company is backed by institutional investors including Fifth Estate, Ellerston Capital, Regal, Perennial Partners and Washington H. Soul Pattinson.
Investment
Highlights
- Your investment will be in a Wholesale Holdings Nicolab Trust (Trust) established for the sole purpose of acquiring the Underlying Asset, arranged by Reach.
- Exposure to the Underlying Asset via a Trust for eligible S708 investors only.
- The Trust will purchase Non-participating Series A Convertible Preference Shares at a share price of $1 per share (Underlying Asset).
- Market Capitalisation of $126,422,044 (pre-money). This excludes the Company’s recently completed tranche 1 for $7,350,000, of a total $15m raise.
- 15% dividend per annum,accrued on a daily basis.
- 1 x non-participating liquidation preference.
- Convertible into ordinary shares (together with accrued but unpaid dividend) at the holder’s election, or immediately prior to a liquidity event.
- Standard protective provisions and information rights.
- Refer to Term Sheet for full explanation.
Request offer docs
Wholesale Only*
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets have been engaged by Nicolab to manage this offer and will receive fees based on the uptake of this offer.
Reach Markets have been engaged by Nicolab to manage this offer and will receive fees based on the uptake of this offer.
*Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
- A gross income of $250,000 or more per annum in each of the previous two financial years; or
- Net assets of at least $2.5 million; and
- A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)
Any advice provided by Reach Markets, including on its website and by its representatives, is general advice only and does not consider your personal objectives, financial situation or needs, and you should consider whether it is appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice. You need to also read any relevant offer documents to understand the features, risks and returns associated with the investment to make your own informed decision.
Please click here to read our full general advice warning.
If you are thinking about acquiring a financial product, you should consider our Reach Markets Financial Services Guide (FSG) including the Privacy Statement.
Past performance is not a reliable indicator of future performance.